MLN Matters Articles
MLN Matters® Articles
These Articles explain national Medicare policies on coverage, billing, and payment rules for specific provider types. Sometimes we explain information in an MLN Connects® newsletter message instead of an MLN Matters® Article. If there’s an Article or a newsletter message, you’ll find it in the “Provider Education” column.
The COVID-19 public health emergency (PHE) ended on May 11, 2023. View Infectious diseases for a list of waivers and flexibilities that were in place during the PHE.
You can filter by subject or Article number. To search all years, leave the Transmittal Year as "Any."
Transmittal # | Issue Date | Subject | Implementation Date | CR # | Provider Education | Provider Education Release Date | Provider Education Revision Date Sort ascending |
---|---|---|---|---|---|---|---|
R12369CP | Implementation of Rural Emergency Hospital (REH) Provider Type |
12820 | MLN Fact Sheet | ||||
R11900CP | Implementation of Rural Emergency Hospital (REH) Provider Type |
12820 | MLN Fact Sheet | ||||
SE19006 | Medicare Part B Clinical Laboratory Fee Schedule: Revised Information for Laboratories on… |
SE19006 | |||||
R12291CP | Separate Payment for Disposable Negative Pressure Wound Therapy Devices on Home… |
13244 | MLN Matters Article MM13244 | ||||
R12291BP | Separate Payment for Disposable Negative Pressure Wound Therapy Devices on Home… |
13244 | MLN Matters Article MM13244 | ||||
R12380CP | Diagnosis Code Update for Add-on Payments for Blood Clotting Factor… |
13381 | MLN Matters Article MM13381 | ||||
R12379CP | Implementation of New Benefit Category for Lymphedema Compression Treatment Items… |
13286 | MLN Matters Article MM13286 | ||||
R12355OTN | International Classification of Diseases, 10th Revision (ICD-10) and Other Coding Revisions to… |
13278 | MLN Matters Article MM13278 | ||||
R12252CP | Implementation of the New Home Intravenous Immune Globulin (IVIG… |
13217 | MLN Fact Sheet | ||||
R12352BP | Manual Updates for Coverage of Intravenous Immune Globulin (IVIG) For Treatment of… |
13414 | MLN Fact Sheet |